CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 06:00PM GMT
Release Date Price: R$29.84
Lisa Christine Gill
JP Morgan Chase & Co, Research Division - Senior Publishing Analyst

Okay, great. Good morning. My name is Lisa Gill. I'm the health care technology and distribution analyst at JPMorgan. We're going to do something a little bit different this morning, and we're going to actually do a fireside chat. So I have with me the CVS health team.

With me this morning is CEO, Larry Merlo. To Larry's left is CFO, Eva Boratto. And to Eva's left is President of the Healthcare -- Health Benefits business is Karen Lynch. So the breakout will be in the Georgian Room across the hall. Larry is going to start with just a couple of quick slides, and then we're going to get into the discussion. So.

Larry J. Merlo
CVS Health Corporation - President, CEO & Director

Okay. Well, thanks, Lisa. And first of all, let me just call your attention to the slide with our forward-looking statements. And before I turn it back to Lisa to get into the questions, I just want to spend a few minutes to briefly discuss CVS Health, how we're transforming the way we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot